European Journal of Pediatrics

, Volume 155, Issue 11, pp 921–927

Inherited defects of the protein C anticoagulant system in childhood thrombo-embolism

  • U. Nowak-Göttl
  • K. Auberger
  • U. Göbel
  • W. Kreuz
  • R. Schneppenheim
  • H. Vielhaber
  • W. Zenz
  • B. Zieger


Childhood thrombo-embolism is mostly the result of inherited thrombophilia or vascular insults combined with risk factors such as peripartal asphyxia, fetopathia diabetica, exsiccosis, septicaemia, central lines, congenital heart disease, cancer, trauma, surgery or elevated antiphospholipid antibodies. Inherited thrombophilia includes mainly defects of the protein C pathway, resistance to activated protein C, protein C or protein S deficiency. Resistance to activated protein C, in the majority of cases caused by the point mutation Arg 506 Gln of the factor V gene, has emerged as the most important hereditary cause of thrombo-embolism in adults and children. However, since an acquired risk of thrombo-embolic complications frequently masks the inherited deficiency in affected children, children with thrombo-embolism should have adequate laboratory evaluation for inherited coagulation disorders, especially the protein C pathway. Until more data on childhood thrombo-embolism are available, treatment recommendations will continue to be extrapolated from guidelines for adults.

Key words

Resistance to activated protein C (APCR) Protein C Protein S Childhood thrombo-embolism 



activated protein C


resistance to the anticoagulatory effect of protein C


activated partial thromboplastin time


C4b binding protein


fresh frozen plasma


protein C


protein S


tissue factor


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Alessi MC, Aillaud MF, Paut O, Roquelaure B, Alhenc-Gelas M, Pellissier MC, Ghanen N, Juhan-Vague I (1996) Purpura fulminans in a patient homozygous for a mutation in the protein C gene — prenatal diagnosis in a subsequent pregnancy. Thromb Haemost 75:520–521Google Scholar
  2. 2.
    Allaart CF, Poort S, Rosendal F, Reitsma P, Bertina R (1993) Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 341:134–138Google Scholar
  3. 3.
    Amer L, Kisiel W, Searles RP, Williams RC Jr (1990) Impairment of the protein C anticoagulant pathway in a patient with systemic lupus erythematosus, anticardiolipin antibodies and thrombosis. Thromb Res 57:247–258Google Scholar
  4. 4.
    Andrew M (1995) Developmental hemostasis: relevance to thromboembolic complications in pediatric patients. Thromb Haemost 74:415–425Google Scholar
  5. 5.
    Andrew M, Paes B, Milner R, Johnston M (1990) Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 12:95–104Google Scholar
  6. 6.
    Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L (1992) Maturation of the hemostatic system during childhood. Blood 80:1998–2005Google Scholar
  7. 7.
    Andrew M, David M, Adams M (1993) Venous thromboembolic complications in children. J Pediatr 123:337–346Google Scholar
  8. 8.
    Arav-Bogner R, Reif S, Bujanover Y (1995) Portal vein thrombosis caused by protein C and protein S deficiency associated with cytomegalovirus infection. J Pediatr 126:586–588Google Scholar
  9. 9.
    Arnout J, Vanrusselt M, Vermylen J (1995) Resistance to activated protein C in a population of patients with antiphospholipid antibodies. Thromb Haemost 73:1275Google Scholar
  10. 10.
    Auberger K (1992) Evaluation of a new protein C concentrate and comparison of protein C assays in a child with congenital protein C deficiency. Ann Hematol 64:146–151Google Scholar
  11. 11.
    Baliga V, Thwaites R, Tillyer ML, Minford A, Parapia L, Allgrove J (1995) Homozygous protein C deficiency — management with protein C concentrate. Eur J Pediatr 154:534–535Google Scholar
  12. 12.
    Bandello F, D'Angelo SV, Parlavecchia M, Tavola A, Valle PD, Brancato R, D'Angelo A (1994) Hypercoagulability and high lipoprotein (a) levels in patients with central retinal vein occlusion. Thromb Haemost 72:39–43Google Scholar
  13. 13.
    Bertina RM, Ploos Van Amstel HK, Wijngaarden A van, Coenen J, Leemhuis MP, Deutz Terlouw PP, Linden IK van der, Reitsma PH (1990) Heerlen polymorphism of protein S, an immunologic polymorphism due to dimorphism of residue 460. Blood 76:538–548Google Scholar
  14. 14.
    Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, Ronde H de, Velden PA van der, Reitsma PH (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64–67Google Scholar
  15. 15.
    Bick RL, Baker WF (1994) The antiphospholipid and thrombosis syndromes. Med Clin North Am 78:667–684Google Scholar
  16. 16.
    Bick R, Ucar K (1992) Hypercoagulability and thrombosis. Hematol Oncol Clin North Am 6:1421–1429Google Scholar
  17. 17.
    Bovill EG, Bauer KA, Dickermann JD, Callas P, West B (1989) The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood 73:712–717Google Scholar
  18. 18.
    Cooper PC, Hampton KK, Makris M, Abuzenadah A, Paul B, Preston FE (1994) Further evidence that activated protein C resistance can be misdiagnosed as inherited functional protein S deficiency. Br J Haematol 88:201–203Google Scholar
  19. 19.
    Dahlbäck B (1986) Inhibition of protein C cofactor function of human and bovine protein S by C4b-binding protein. J Biol Chem 261:12022–12027Google Scholar
  20. 20.
    Dahlbäck B (1991) Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system. Thromb Haemost 66:49–61Google Scholar
  21. 21.
    Dahlbäck B (1995) New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg 506 to Gln mutation in factor V as a pathogenetic risk factor. Thromb Haemost 74:139–148Google Scholar
  22. 22.
    Dahlbäck B (1995) Factor V gene mutation causing inherited resistance to activated protein C as a basis for venous thromboembolism. J Int Med 237:221–227Google Scholar
  23. 23.
    Dahlbäck B, Carlsson M (1991) Factor VIII defect associated with familial thrombophilia. Thromb Haemost 65:658Google Scholar
  24. 24.
    Dahlbäck B, Carlsson M, Svensson PJ (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90:1004–1008Google Scholar
  25. 25.
    D'Angelo SV, Mazzola G, Valle PD, Testa S, Pattarini E, D'Angelo A (1995) Variable interference of activated protein C resistance in the measurement of protein S activity by commercial assays. Thromb Res 77:375–378Google Scholar
  26. 26.
    David M, Andrew M (1993) Venous thromboembolic complications in children. J Pediatr 123:337–346Google Scholar
  27. 27.
    David M, Manco-Johnson M, Andrew M (1995) Diagnosis and treatment of venous thromboembolism in children and adolescents. On behalf of the subcommittee on perinatal haemostasis of the scientific and standardization committee of the ISTH. Thromb Haemost 74:791–792Google Scholar
  28. 28.
    Dreyfuß M, Magny JF, Bridey F, Schwarz HP, Planche C, Dehan M, Tchernia G (1991) Treatment of homozygous protein C deficiency and neonatal purpura fulminans with purified protein C concentrate. N Engl J Med 325:1565–1568Google Scholar
  29. 29.
    Edenbrandt CM, Lindwall A, Wydro R, Stenflo J (1990) Molecular analysis of the gene for vitamin K-dependent protein S and its pseudogene. Cloning and partial gene organization. Biochemistry 29:7861–7868Google Scholar
  30. 30.
    Esmon CT (1989) The role of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 264:4743–4749Google Scholar
  31. 31.
    Faioni EM, Boyer-Neumann C, Franchi F, Wolf M, Meyer D, Mannucci P (1994) Another protein S functional assay is sensitive to resistance to activated protein C. Thromb Haemost 72:643–651Google Scholar
  32. 32.
    Foster DC, Yoshitake S, Davie EW (1985) The nucleotide sequence of the gene for human protein C. Proc Natl Acad Sci USA 82:4673–4677Google Scholar
  33. 33.
    Gandrille S, Borgel D, Eschwege-Gufflet V, Aillaud MF, Dreyfuß M, Matheron C, Gaussem P, Abgrall JF, Jude B, Sie P, Toulon P, Aiach M (1995) Identification of 15 different candidate causal point mutations and three polymorphisms in 19 patients with protein S deficiency using a scanning method for the analysis of the protein S active gene. Blood 85:130–139Google Scholar
  34. 34.
    Gladson CL, Scharrer I, Hach V, Beck KM, Griffin JH (1988) The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemost 59:18–22Google Scholar
  35. 35.
    Göbel U (1994) Inherited or acquired disorders of blood coagulation in children with neurovascular complications. Neuropediatrics 25:4–7Google Scholar
  36. 36.
    Gomez E, Ledford MR, Pegelow CH, Reitsma PH, Bettina RM (1994) Homozygous protein S deficiency caused by one base pair deletion that leads to a stop codon in exon III of the protein S gene. Thromb Haemost 71:723–726Google Scholar
  37. 37.
    Gurewich V, Pannell R, Louie S, Kelley P, Suddith RL, Greenlee R (1984) Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species. J Clin Invest 73:1731–1739Google Scholar
  38. 38.
    Hayashi T, Nishioka J, Shigekiyo T, Saito S, Suzuki K (1994) Protein S Tokushima: abnormal molecule with a substitution of Glu for Lys-155 in the second epidermal growth factor-like domain of protein S. Blood 83:683–690Google Scholar
  39. 39.
    Haverkate F, Samama M (1995) Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC subcommittee on fibrinogen. Thromb Haemost 73:151–161Google Scholar
  40. 40.
    Heijboer H, Brandjed D, Buller H, Sturk A, Wouter ten Cate J (1990) Deficiencies of coagulation inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med 323:1512–1516Google Scholar
  41. 41.
    Hirsch J (1991) Oral anticoagulant drugs. N Engl J Med 342:1865–1875Google Scholar
  42. 42.
    Ichinose A, Fujikawa K, Suyama T (1986) The activation of prourokinase by plasma kallikrein and ist inactivation by thrombin. J Biol Chem 261:3486–3489Google Scholar
  43. 43.
    Jaffe EA (1991) Endothelial structure and function. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ (eds) Hematology, basic principles and practice. Churchill-Livingstone, New York, pp 1198–1213Google Scholar
  44. 44.
    Kluft C (1994) Constitutive synthesis of tissue-type plasminogen activator (tPA) and plasminogen activator inhibitor type 1 (PAT-1): conditions and therapeutic targets. Fibrinolysis 8(2):1–7Google Scholar
  45. 45.
    Kodish E, Potter C, Kirschbaum N, Foster P (1995) Activated protein C resistance in a neonate with venous thrombosis. J Pediatr 127:645–648Google Scholar
  46. 46.
    Koster T, Rosendaal FR, Ronde H de, Briet E, Vandenbroucke JP, Bertina RM (1993) Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 342:1503–1506Google Scholar
  47. 47.
    Levy M, Benson L, Burrows PE, Bentur Y, Strong DK, Smith J, Johnson D, Jacobson S, Koren G (1991) Tissue plasminogen activator for the treatment of thromboembolism in infants and children. J Pediatr 118:467–472Google Scholar
  48. 48.
    Mahn J, Laurell M, Nilsson I, Dahlbäck B (1992) Thromboembolic disease — critical evaluation of laboratory investigation. Thromb Haemost 8:7–13Google Scholar
  49. 49.
    Mannucci PM, Tripodi A (1987) Laboratory screening of inherited thrombotic syndromes. Thromb Haemost 57:247–251Google Scholar
  50. 50.
    Marlar RA, Neumann A (1990) Neonatal purpura fulminans due to homozygous protein C or S deficiencies. Sem Thromb Hemost 16:299–309Google Scholar
  51. 51.
    Miletich J, Sherman L, Broze G (1987) Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 317:991–996Google Scholar
  52. 52.
    Müller EM, Ehrenthal W, Hafner G, Schranz D (1996) Purpura fulminans in severe congenital protein C deficiency: monitoring of treatment with protein C concentrate. Eur J Pediatr 155:20–25Google Scholar
  53. 53.
    Nowak-Göttl U, Schwabe D, Schneider W, Schlösser R, Kreuz W (1992) Thrombolysis with recombinant tissue type plasminogen activator in renal venous thrombosis in infancy. Lancet 340:1105Google Scholar
  54. 54.
    Nowak-Göttl U, Funk M, Mosch G, Wegerich B, Kornhuber B, Breddin HK (1994) Univariate tolerance regions for fibrinogen, antithrombin III, protein C, protein S, plasminogen and α2-antiplasmin in children using the new automated coagulation laboratory (ACL) method. Klin Pädiatr 206:437–439Google Scholar
  55. 55.
    Nowak-Göttl U, Ashka I, Koch HG, Boos J, Dockhorn-Dworniczak B, Deufel T, Jürgens H, Kohlhase B, Kuhn N, Laupert A, Rath B, Wolff JEA, Schneppenheim R (1995) Resistance to activated protein C (APCR) in children with acute lymphoblastic leukaemia — the need for a prospective multicentre study. Blood Coag Fibrinol 6:761–764Google Scholar
  56. 56.
    Nowak-Göttl U, Koch HG, Aschka I, Kohlhase B, Vielhaber H, Kurlemann G, Oleszuk-Rasche K, Kehl HG, Jürgens H, Schneppenheim R (1996) Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism. Br J Haematol 92:992–998Google Scholar
  57. 57.
    Nowak-Göttl U, Kohlhase B, Vielhaber H, Aschka I, Schneppenheim R, Jürgens H (1996) APC resistance in neonates and infants: adjustment of the aPTT-based method. Thromb Res 81:665–670Google Scholar
  58. 58.
    Nuss R, Hys T, Manco-Johnson M (1995) Childhood thrombosis. Pediatrics 96:291–294Google Scholar
  59. 59.
    Petäjä J, Jalanko H, Holmberg C, Kinmmen S, Syrjälä (1995) Resistance to activated protein C as an underlying cause of recurrent venous thrombosis during relapsing nephrotic syndrome. J Pediatr 127:103–105Google Scholar
  60. 60.
    Ploos Van Amstel HK, Zanden AL van der, Bakker E, Reitsma PH, Bettina RM (1987) Two genes homologous with human protein S cDNA are located on chromosome 3. Thromb Haemost 58:982–987Google Scholar
  61. 61.
    Ploos Van Amstel HK, Huisman MV, Reitsma PH, Wouter ten Cate J, Bettina RM (1989) Partial protein S gene deletion in a family with hereditary thrombophilia. Blood 73:479–483Google Scholar
  62. 62.
    Ploos Van Amstel HK, Reitsma PH, Bertina RM (1989) The human protein S locus: identification of the PS alpha gene as a site of liver protein S messenger RNA synthesis. Biochem Biophys Res Commun 157:1033–1038Google Scholar
  63. 63.
    Ploos Van Amstel HK, Reitsma PH, Hamulyak K, Smulders CE de, Mannucci PM, Bettina RM (1989) A mutation in the protein S pseudogene is linked to protein S deficiency in a thrombophilic family. Thromb Haemost 62:897–901Google Scholar
  64. 64.
    Ploos Van Amstel HK, Reitsma PH, Logt CP van der, Bertina RM (1990) Intron-exon organisation of the active human protein S gene PS alpha and its pseudogene PS beta: duplication and silencing during primate evolution. Biochemistry 29:7853–7861Google Scholar
  65. 65.
    Plutzky J, Hoskins JA, Long GL, Crabtree GR (1986) Evolution and organization of the human protein C gene. Proc Natl Acad Sci USA 83:546–550Google Scholar
  66. 66.
    Reitsma PH, Poort SR, Allaart CF, Briet E, Bettina RM (1991) The spectrum of genetic defects in a panel of 40 Dutch families with symptomatic protein C deficiency type I: Heterogenity and founder effects. Blood 78:890–894Google Scholar
  67. 67.
    Reitsma PH, Ploos Van Amstel HK, Bertina RM (1994) Three novel mutations in five unrelated subjects with hereditary protein S deficiency type I. J Clin Invest 93:486–492Google Scholar
  68. 68.
    Reitsma PH, Bernardi F, Doig RG, Gandrille S, Greengard JS, Ireland H, Krawczak M, Lind B, Long GL, Poort SR, Saito H, Sala N, Witt I, Cooper DN (1995) Protein C deficiency: a database of mutations, 1995 update. Thromb Haemost 73:786–879Google Scholar
  69. 69.
    Rodgers L, Luther C. Streptokinase therapy for deep vein thrombosis: a comprehensive review of the English literature. Am J Med 88:389–395Google Scholar
  70. 70.
    Rosenbaum T, Rammos S, Kniemeyer HW, Göbel U (1993) Extended deep vein and inferior vena cava thrombosis in a 15-year-old boy: successful lysis with recombinant tissue type plasminogen activator 2 weeks after onset symptoms. Eur J Pediatr 152:978–980Google Scholar
  71. 71.
    Ryan CA, Andrew M (1992) Failure of thrombolytic therapy in four children with extensive thrombosis. Am J Dis Child 146:187–193Google Scholar
  72. 72.
    Schmidel DK, Nelson RM, Broxson EH, Comp PC, Marlar RA, Long GL (1991) A 5.3-kb deletion including exon XIII of the protein S a gene occurs in two protein S-deficient families. Blood 77:551–559Google Scholar
  73. 73.
    Schmidt B, Andrew M (1995) Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 96:939–943Google Scholar
  74. 74.
    Schwabe D, Schlösser R, Auberger K, Kries R von, Nowak-Göttl U (1996) Thrombolyse mit rt-PA im 1. Lebensjahr. Hämostaseologie (in press)Google Scholar
  75. 75.
    Shen L, Dahlbäck B (1994) Factor V and protein C in degradation of factor VIIIa. J Biol Chem 269:18735–18738Google Scholar
  76. 76.
    Simioni P, De Ronde H, Prandoni P, Saladini M, Bertina RM, Girolami A (1995) Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds. Stroke 26:885–890Google Scholar
  77. 77.
    Svensson PJ, Dahlbäck B (1994) Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 330:517–522Google Scholar
  78. 78.
    Taberno M, Tomas J, Alberca I, Orfao A, Borrasca A, Vincente V (1991) Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis. Am J Hematol 36:249–254Google Scholar
  79. 79.
    Uziel Y, Laxer RM, Blaser S, Andrew M, Schneider R, Silverman ED (1995) Cerebral vein thrombosis in childhood systemic lupus erythematosus. J Pediatr 126:722–727Google Scholar
  80. 80.
    Vielhaber H, Kohlhase B, Kehl HG, Fliedner M, Kececioglu D, Dockhorn-Dworniczak B, Kehrel B, Veltmann H, Vogt J, Nowak-Göttl U (1996) Flush heparin during cardiac catherisation prevents long-term coagulation activation in children without APC-resistance — preliminary results. Thromb Res 81:651–656Google Scholar
  81. 81.
    Whitlock J, Janco R, Phillips J (1989) Inherited hypercoagulable states in children. Am J Pediatr Hematol Oncol 11:170–173Google Scholar
  82. 82.
    Wiman B, Hamsten A (1990) The fibrinolytic enzyme system and its role in the etiology of thromboembolic disease. Sem Thromb Haemost 16:207–214Google Scholar
  83. 83.
    Zenz W, Muntean W, Gallistl S, Leschnik B, Beitzke A (1994) Inherited resistance to activated protein C in a boy with multiple thromboses in early infancy. Eur J Pediatr 154:285–288Google Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • U. Nowak-Göttl
    • 1
  • K. Auberger
    • 2
  • U. Göbel
    • 3
  • W. Kreuz
    • 4
  • R. Schneppenheim
    • 5
  • H. Vielhaber
    • 1
  • W. Zenz
    • 6
  • B. Zieger
    • 7
  1. 1.Department of Paediatrics, Paediatric Haematology and OncologyWestfälische Wilhelms-UniversitätMünsterGermany
  2. 2.Department of PaediatricsUniversity HospitalMunichGermany
  3. 3.Department of PaediatricsUniversity HospitalDüsseldorfGermany
  4. 4.Department of PaediatricsUniversity HospitalFrankfurt-am-MainGermany
  5. 5.Department of PaediatricsUniversity HospitalKielGermany
  6. 6.Department of PaediatricsUniversity HospitalGrazAustria
  7. 7.Department of PaediatricsUniversity HospitalFreiburgGermany

Personalised recommendations